Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Aphios Awarded United States Patent

Abstract:
Patent for Compositions and Methods for Inhibiting 5-Alpha Reductase

Aphios Awarded United States Patent

Woburn, MA | Posted on July 27th, 2010

Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-á Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (á) reductase enzyme.

5-á reductase is responsible for causing benign prostatic hyperplasia (BPH) and male pattern baldness (alopecia) in men as well as hirsutism (male-pattern body hair) in women. An estimated 50% of men above 50 in the United States have BPH that causes urinary hesitation and frequent urination and night time visits to the bathroom. The incidence of BPH increases to 60% for men over sixty, 70% for men above 70, 80% or men above 80 following an Arrhenius-type plot. BPH has been linked to the incidence of prostate cancer that is the most prevalent cancer among men; and the second leading cause of cancer death among men in the US.

More than 500,000 prostate cancer cases are diagnosed each year in the United States, 1 in 6 American males will develop prostate cancer and 300,000 die of prostate cancer each year.

This invention is utilized in Aphios' SuperCool™ Palmetto and Sperol™ products for several conditions including benign prostatic hyperplasia, prostatic cancer, hirsutism, acne, male pattern baldness, seborrhea, and other androgen hyperactivity diseases. The active pharmaceutical ingredient, finasteride, of Merck's Proscar® for BPH and Propecia® for male pattern baldness work by the same mechanism of 5-á reductase inhibition as SuperCool™ Palmetto and Sperol™, which are natural alternatives to these drugs with fewer side effects.

The source for the active pharmaceutical ingredients in both SuperCool™ Palmetto and Sperol™ is the Serenoa repens (Saw Palmetto) berry.

The therapeutic compositions of the invention were discovered using Aphios' patented SuperFluids™ CXF drug discovery technologies and manufactured using Aphios' patented SuperFluids™ CXP drug manufacturing technologies. These technologies ensure purity, increase extraction efficiency and overall yield, and are environmentally friendly. These technologies are also utilized in Aphios' Zindol® and SuperCool™ Gingerol products for nausea and vomiting, and Xantol™ and SuperCool™ St. John's products for emotional well-being, relaxed outlook, and positive moods.

Research leading to this invention was in part conducted under a SBIR grant 1R43 AT00321-01 from the National Center of Complementary and Alternative Medicine (NCCAM), National Institutes of Health (NIH). The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of NCCAM and NIH.

####

About Aphios
Aphios®, www.aphios.com and www.SuperCoolHealth.com, is a “green” biotechnology company developing enabling technology platforms for improved drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Based on these platforms, we are developing enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders.

For more information, please click here

Contacts:
Trevor P. Castor, Ph.D.
CEO
781-932-6933

Copyright © Aphios

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014

Nanoparticle technology triples the production of biogas October 23rd, 2014

Govt.-Legislation/Regulation/Funding/Policy

Novel Rocket Design Flight Tested: New Rocket Propellant and Motor Design Offers High Performance and Safety October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

Nanomedicine

NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014

Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Announcements

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Patents/IP/Tech Transfer/Licensing

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014

Aculon Receives Patent for Application of Enhanced Bonding Layers on Titanium October 9th, 2014

harmaEngine will join Nanobiotix’ pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific: PharmaEngine to make milestone payment to Nanobiotix in October 2014 to recognize the value created October 8th, 2014

Nanobiotechnology

NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014

Nanoparticle technology triples the production of biogas October 23rd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

‘Designer’ nanodevice could improve treatment options for cancer sufferers October 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE